236 related articles for article (PubMed ID: 34414452)
1. Theories behind the effect of starch‑ and sucrose‑reduced diets on gastrointestinal symptoms in irritable bowel syndrome (Review).
Ohlsson B
Mol Med Rep; 2021 Oct; 24(4):. PubMed ID: 34414452
[TBL] [Abstract][Full Text] [Related]
2. Sucrase-Isomaltase Deficiency as a Potential Masquerader in Irritable Bowel Syndrome.
Kim SB; Calmet FH; Garrido J; Garcia-Buitrago MT; Moshiree B
Dig Dis Sci; 2020 Feb; 65(2):534-540. PubMed ID: 31493040
[TBL] [Abstract][Full Text] [Related]
3. A starch- and sucrose-reduced diet may lead to improvement of intestinal and extraintestinal symptoms in more conditions than irritable bowel syndrome and congenital sucrase-isomaltase deficiency.
Roth B; Ohlsson B
Nutrition; 2024 Jan; 117():112254. PubMed ID: 37924624
[TBL] [Abstract][Full Text] [Related]
4. Relationships among Dietary Intakes and Persistent Gastrointestinal Symptoms in Patients Receiving Enzyme Treatment for Genetic Sucrase-Isomaltase Deficiency.
Boney A; Elser HE; Silver HJ
J Acad Nutr Diet; 2018 Mar; 118(3):440-447. PubMed ID: 29311037
[TBL] [Abstract][Full Text] [Related]
5. Irregular Dietary Habits with a High Intake of Cereals and Sweets Are Associated with More Severe Gastrointestinal Symptoms in IBS Patients.
Nilholm C; Larsson E; Roth B; Gustafsson R; Ohlsson B
Nutrients; 2019 Jun; 11(6):. PubMed ID: 31195706
[TBL] [Abstract][Full Text] [Related]
6. Colon Hypersensitivity to Distension, Rather Than Excessive Gas Production, Produces Carbohydrate-Related Symptoms in Individuals With Irritable Bowel Syndrome.
Major G; Pritchard S; Murray K; Alappadan JP; Hoad CL; Marciani L; Gowland P; Spiller R
Gastroenterology; 2017 Jan; 152(1):124-133.e2. PubMed ID: 27746233
[TBL] [Abstract][Full Text] [Related]
7. Fructose and irritable bowel syndrome.
Melchior C; Douard V; Coëffier M; Gourcerol G
Nutr Res Rev; 2020 Dec; 33(2):235-243. PubMed ID: 32122419
[TBL] [Abstract][Full Text] [Related]
8. Is fructose malabsorption a cause of irritable bowel syndrome?
DiNicolantonio JJ; Lucan SC
Med Hypotheses; 2015 Sep; 85(3):295-7. PubMed ID: 26059250
[TBL] [Abstract][Full Text] [Related]
9. Assessment of a 4-Week Starch- and Sucrose-Reduced Diet and Its Effects on Gastrointestinal Symptoms and Inflammatory Parameters among Patients with Irritable Bowel Syndrome.
Nilholm C; Larsson E; Sonestedt E; Roth B; Ohlsson B
Nutrients; 2021 Jan; 13(2):. PubMed ID: 33525489
[TBL] [Abstract][Full Text] [Related]
10. Genetic and acquired sucrase-isomaltase deficiency: A clinical review.
Danialifar TF; Chumpitazi BP; Mehta DI; Di Lorenzo C
J Pediatr Gastroenterol Nutr; 2024 Apr; 78(4):774-782. PubMed ID: 38327254
[TBL] [Abstract][Full Text] [Related]
11. Functional variants in the sucrase-isomaltase gene associate with increased risk of irritable bowel syndrome.
Henström M; Diekmann L; Bonfiglio F; Hadizadeh F; Kuech EM; von Köckritz-Blickwede M; Thingholm LB; Zheng T; Assadi G; Dierks C; Heine M; Philipp U; Distl O; Money ME; Belheouane M; Heinsen FA; Rafter J; Nardone G; Cuomo R; Usai-Satta P; Galeazzi F; Neri M; Walter S; Simrén M; Karling P; Ohlsson B; Schmidt PT; Lindberg G; Dlugosz A; Agreus L; Andreasson A; Mayer E; Baines JF; Engstrand L; Portincasa P; Bellini M; Stanghellini V; Barbara G; Chang L; Camilleri M; Franke A; Naim HY; D'Amato M
Gut; 2018 Feb; 67(2):263-270. PubMed ID: 27872184
[TBL] [Abstract][Full Text] [Related]
12. Severe pathogenic variants of intestinal sucrase-isomaltase interact avidly with the wild type enzyme and negatively impact its function and trafficking.
Husein DM; Rizk S; Hoter A; Wanes D; D'Amato M; Naim HY
Biochim Biophys Acta Mol Basis Dis; 2022 Nov; 1868(11):166523. PubMed ID: 35985447
[TBL] [Abstract][Full Text] [Related]
13. Differential Effects of Sucrase-Isomaltase Mutants on Its Trafficking and Function in Irritable Bowel Syndrome: Similarities to Congenital Sucrase-Isomaltase Deficiency.
Husein DM; Rizk S; Naim HY
Nutrients; 2020 Dec; 13(1):. PubMed ID: 33375084
[TBL] [Abstract][Full Text] [Related]
14. A Starch- and Sucrose-Reduced Diet in Irritable Bowel Syndrome Leads to Lower Circulating Levels of PAI-1 and Visfatin: A Randomized Controlled Study.
Roth B; Myllyvainio J; D'Amato M; Larsson E; Ohlsson B
Nutrients; 2022 Apr; 14(9):. PubMed ID: 35565656
[TBL] [Abstract][Full Text] [Related]
15. Improved Starch Digestion of Sucrase-deficient Shrews Treated With Oral Glucoamylase Enzyme Supplements.
Nichols BL; Avery SE; Quezada-Calvillo R; Kilani SB; Lin AH; Burrin DG; Hodges BE; Chacko SK; Opekun AR; Hindawy ME; Hamaker BR; Oda SI
J Pediatr Gastroenterol Nutr; 2017 Aug; 65(2):e35-e42. PubMed ID: 28267073
[TBL] [Abstract][Full Text] [Related]
16. A Dietary Intervention with Reduction of Starch and Sucrose Leads to Reduced Gastrointestinal and Extra-Intestinal Symptoms in IBS Patients.
Nilholm C; Roth B; Ohlsson B
Nutrients; 2019 Jul; 11(7):. PubMed ID: 31330810
[TBL] [Abstract][Full Text] [Related]
17. Sucrase-isomaltase genotype and response to a starch-reduced and sucrose-reduced diet in IBS-D patients.
Zamfir-Taranu A; Löscher BS; Husein DM; Hoter A; Garcia-Etxebarria K; Etxeberria U; Gayoso L; Mayr G; Nilholm C; Gustafsson RJ; Ozaydin O; Zheng T; Esteban-Blanco C; Bozzarelli I; Bonfiglio F; Rizk S; Franke A; Bujanda L; Naim HY; Ohlsson B; D'Amato M
Gut; 2024 Mar; 73(4):706-708. PubMed ID: 36878682
[No Abstract] [Full Text] [Related]
18. Role of Diet in Diarrhea-predominant Irritable Bowel Syndrome.
Singh P; Nee J
J Clin Gastroenterol; 2021 Jan; 55(1):25-29. PubMed ID: 33060435
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of a Restrictive Diet in Irritable Bowel Syndrome: A Systematic Review and Network Meta-analysis.
Yu SJ; Lee HS; Gung HJ; Kim JS; Kim KB; Kwon YH; Kim JH; Koo HS; Shin HD; Jee SR; Lee HB; Kim J; Park HW;
Korean J Gastroenterol; 2022 Jul; 80(1):6-16. PubMed ID: 35879058
[TBL] [Abstract][Full Text] [Related]
20. Low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols diet compared with traditional dietary advice for diarrhea-predominant irritable bowel syndrome: a parallel-group, randomized controlled trial with analysis of clinical and microbiological factors associated with patient outcomes.
Zhang Y; Feng L; Wang X; Fox M; Luo L; Du L; Chen B; Chen X; He H; Zhu S; Hu Z; Chen S; Long Y; Zhu Y; Xu L; Deng Y; Misselwitz B; Lang BM; Yilmaz B; Kim JJ; Owyang C; Dai N
Am J Clin Nutr; 2021 Jun; 113(6):1531-1545. PubMed ID: 33740048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
